News

A vaccine to prevent pancreatic cancer in high-risk individuals was safe and elicited durable immune responses

Cancer survivors and providers differ in views on medical cannabis, study finds

Immune cells use previously unknown pathway to eliminate AML

Virtual tumour predict response to liver cancer immunotherapy

ECOG-ACRIN ENDURANCE trial findings provide the first randomised evidence on the optimal duration of lenalidomide maintenance for patients with newly diagnosed multiple myeloma

Clinic-led study finds no improvement in overall survival from longer multiple myeloma maintenance therapy

New cancer drug shows promise in mesothelioma trial

Virtual, sustained smoking cessation program for cancer patients doubles quitting rate, clinical trial shows

Immune ecotypes may explain multiple myeloma outcomes missed by disease staging

Researchers link gut microbe to cancer-fighting immune response

Scientists uncover genetic clues from a tumour-prone reptile that could advance cancer research

“Acts as a ‘protective barrier’ in blood vessels, but disappears in tumour tissue”... Mussel protein opens a new path for pancreatic cancer treatment